LOS ANGELES, July 21, 2014 /PRNewswire/ --
The Louisiana Organ Procurement Agency (LOPA) is utilizing the CompuMed, Inc. (OTCPink: CMPD) Enterprise Organ Procurement Organization (OPO) Solution to improve donor organ recovery. CompuMed Enterprise OPO includes a cloud-based telemedicine platform to provide real-time access to its Board-Certified specialists for diagnostic exam interpretations and critical care consulting.
With CompuMed Enterprise OPO, Organ Procurement Organizations are able to increase the recovery of multiple transplantable organs through a combination of CompuMed serial echocardiogram interpretations and critical care consulting. CompuMed's on-call specialist coverage for organ donor cases can save OPOs 3-12 hours per case and is available weekends, daytime, and after hours.
LOPA is the independent, not-for-profit organ and tissue recovery agency responsible for servicing the state of Louisiana. "We have had limited ability to perform echocardiograms outside of normal clinic hours for years. Now that we have been working with CompuMed, we have been able to perform echocardiograms around the clock with the interpretations being done within the hour. We have been able to decrease our case time and maximize our organ yield leading to more lives being saved," said Joey Boudreaux, LOPA's Chief Clinical Officer.
"As one of the leaders in organ recovery, we very much appreciate the opportunity to have LOPA as a customer. With CompuMed Enterprise OPO, the Louisiana Organ Procurement Agency has the opportunity to increase the number of viable donor hearts and ultimately save more lives," said W. Scott Rombach, CompuMed's President and CEO.
Details of CompuMed's Enterprise OPO Solution can be viewed at compumedinc.com.
About CompuMed, Inc.
CompuMed, Inc. (OTCPink: CMPD) Enterprise Telemedicine Solutions provide patients with the highest level of clinical care at reduced costs. Its telecardiology and teleradiology offerings provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities anywhere in the world. The company has been in business for over 26 years and services over 1,000 clinical settings. CompuMed is headquartered in Los Angeles, CA. Visit CompuMed at http://www.compumedinc.com.
Statements contained in this report, such as statements about revenue, operations, and earnings growth and other financial results are forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All such forward-looking statements including statements concerning the Company's plans, objectives, expectations and intentions are based largely on management's expectations and are subject to and qualified by risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These statements are subject to uncertainties and risks including, without limitation, product and service demand and acceptance, changes in technology, ability to raise capital, the availability of appropriate acquisition candidates and/or business partnerships, economic conditions, the impact of competition and pricing, capacity and supply constraints or difficulties, government regulation and other risks identified in the Company's filings with the Securities and Exchange Commission and OTC Pink operated by OTCMarkets. All such forward-looking statements are expressly qualified by these cautionary statements. The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect events, conditions or circumstances on which any such statement is based after the date hereof, except as required by law.
CompuMed, Inc. Investor Relations: [email protected] or +1-(310)-258-5000 x117